Dermatology & Skin Cancer Center of NM PC

Dermatology & Skin Cancer Center of NM PC was paid $1.19M by Medicaid between Jan 2018 and Dec 2024, across 18 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	660	$35K
2019	2,532	$178K
2020	2,912	$192K
2021	4,163	$242K
2022	3,238	$181K
2023	1,869	$131K
2024incomplete	2,473	$228K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	28%	5,764	5,552	$337K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	18%	2,236	2,212	$216K
88305	Level IV - Surgical pathology, gross and microscopic examination	18%	2,829	2,733	$208K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	17%	1,890	1,860	$197K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	6.9%	1,298	1,288	$81K
11102		6.6%	1,086	1,062	$78K
17000		1.8%	611	574	$21K
17311		1.7%	80	64	$21K
17110		<1%	148	143	$12K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	51	51	$7K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	73	70	$3K
17003		<1%	174	157	$3K

6 more codes

11100		<1%	24	$2K
11104		<1%	15	$1K
11900		<1%	26	$1K
88331		<1%	12	$873.70
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	52	$103.07
G9428	Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors	<1%	1,478	$4.26

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCANGIOLOSI, SANDRA (EXECUTIVE VP OF OPERATIONS)